VivoSeq
Other

Thoracotomy

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Thoracotomy is an early-stage landscape with 0 programs across 1 company. The most active players are Pacira Pharmaceuticals, Inc.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

15/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed6 · 46%
Unknown status3 · 23%
Withdrawn1 · 8%
Not yet recruiting1 · 8%
Terminated1 · 8%
Active, not recruiting1 · 8%

Trial Activity

13 trials

Paravertebral Calcitonin in Thoracotomy
Active, not recruiting·TTanta University·N/A·NCT06330168·92 enrolled
Continue ESPB & Continue ESPB Combined With SAPB for Thoracotomy
Completed··N/A·NCT06685445·60 enrolled
Post- Thoracotomy Paravertebral Block
Completed··Phase 2·NCT02886429·60 enrolled
Duloxetine vs Pregabalin for Thoracotomy Pain
Unknown status··Phase 4·NCT04782310·75 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)